← Back to all trials
Completed
NCT07870057
Innovative Approaches to Identify Causative Genetic Variants in Patients With Unexplained Bleeding Disorders
Conditions: PATIENTS WITH UNEXPLAINED BLEEDING DISORDERS
Sex: All
Ages: 3 Years – N/A
Healthy volunteers: Yes
Enrollment: 122
Sponsor: Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
Location: Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico Milan
Summary
Creation of an Italian network for unexplained bleeding disorders, using integrated multi-omics approaches to improve diagnosis, optimize patient management, and identify novel therapeutic targets.
Eligibility Criteria
Inclusion Criteria:
* Diagnosis of an unexplained bleeding disorder (UBD)
* Willingness to participate in the study and provision of written informed consent
* Ability to provide the blood sample required for the study analyses
* Male or female participants aged 3 years or older (to avoid collecting large blood volumes from newborns)
* ISTH-BAT score \>4 in adult males, \>6 in adult females, and \>3 in children
Exclusion Criteria:
* Age below 3 years
* History of organ transplantation
* Any condition that may impair the participant's ability to comply with the study protocol requirements
* Inability to obtain a blood sample (e.g., poor or limited venous access)
* Diagnosis of an inherited or acquired bleeding disorder
Source: ClinicalTrials.gov (NCT07870057). StuddyBuddy aggregates publicly available trial information.